Bellerophon Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Bellerophon Therapeutics

11/05/2021 17:31

* Bellerophon Therapeutics Inc  BLPH.OQ  reported a quarterly
adjusted loss of 58 cents​​ per share for the quarter ended
in March. The mean expectation of two analysts for the quarter
was for a loss of 71 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Bellerophon Therapeutics Inc's reported EPS for the quarter
was a loss of 58 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Bellerophon Therapeutics Inc shares had fallen by 21.4% this
quarter and lost 38.8% so far this year.
* The company reported a quarterly loss of $5.46 million.
* Wall Street's median 12-month price target for Bellerophon
Therapeutics Inc is $19.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 04:31 p.m. GMT.
​All figures in US dollars